These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12040975)

  • 1. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study.
    Li JY; Zhu JC; Dou JT; Bai WJ; Deng SM; Li M; Huang W; Jin H
    Aging Male; 2002 Mar; 5(1):47-51. PubMed ID: 12040975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral testosterone replacement in Korean patients with PADAM.
    Hong JH; Ahn TY
    Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
    Blümel JE; Chedraui P; Gili SA; Navarro A; Valenzuela K; Vallejo S
    Maturitas; 2009 Aug; 63(4):365-8. PubMed ID: 19481382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
    Haren M; Chapman I; Coates P; Morley J; Wittert G
    Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.
    Park NC; Yan BQ; Chung JM; Lee KM
    Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population.
    Spetz AC; Palmefors L; Skobe RS; Strömstedt MT; Fredriksson MG; Theodorsson E; Hammar ML
    Menopause; 2007; 14(6):999-1005. PubMed ID: 17529900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
    Cavallini G; Caracciolo S; Vitali G; Modenini F; Biagiotti G
    Urology; 2004 Apr; 63(4):641-6. PubMed ID: 15072869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline of serum levels of free testosterone in aging healthy Chinese men.
    Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P
    Aging Male; 2005; 8(3-4):203-6. PubMed ID: 16390747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with human chorionic gonadotropin for PADAM: a preliminary report.
    Tsujimura A; Matsumiya K; Takao T; Miyagawa Y; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
    Aging Male; 2005; 8(3-4):175-9. PubMed ID: 16390742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.
    McLaren D; Siemens DR; Izard J; Black A; Morales A
    BJU Int; 2008 Nov; 102(9):1142-6. PubMed ID: 18540933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
    Pathak AS; Pacificar JS; Shapiro CE; Williams SG
    J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on effects of acupuncture combined with medication on reproductive endocrines in the patient of PADAM].
    Zheng XF; Li P
    Zhongguo Zhen Jiu; 2007 May; 27(5):333-5. PubMed ID: 17645253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
    Corrales JJ; Almeida M; Burgo R; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 2006 Jun; 189(3):595-604. PubMed ID: 16731790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial androgen deficiency and neuropsychiatric symptoms in aging men.
    Amore M
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):49-54. PubMed ID: 16760626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
    Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
    J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.